Vagus nerve stimulation: current status and clinical applications.

Area of Science:

• Neurology
• Epilepsy Research
• Neurosurgery

Background:

• Many epilepsy patients have drug-refractory partial-onset seizures.
• Some patients cannot tolerate anti-epileptic drug (AED) side effects.
• Epilepsy surgery is not suitable for all patients with refractory epilepsy.

Purpose of the Study:

• To evaluate vagus nerve stimulation (VNS) as a non-pharmacological treatment for refractory epilepsy.
• To assess the safety and efficacy of VNS in patients with partial-onset seizures.

Main Methods:

• Vagus nerve stimulation (VNS) was applied to patients with medically-refractory, partial-onset epilepsy.
• Studies included controlled trials in patients on AED therapy and pediatric populations.
• Adverse effects and impact on physiological processes were monitored.

Main Results:

• VNS demonstrated an anticonvulsant effect in animal seizure models.
• VNS showed no significant impact on hepatic metabolism, AED serum concentrations, or laboratory values.
• Controlled studies indicated VNS is effective for partial-onset seizures when used adjunctively.

Conclusions:

• Vagus nerve stimulation (VNS) is a safe and well-tolerated adjunctive therapy for refractory partial-onset epilepsy.
• Adverse effects of VNS are typically mild, manageable, and related to stimulation settings.
• VNS represents a promising non-pharmacological treatment option for epilepsy patients unresponsive to or intolerant of AEDs.